7LD
(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide
Created: | 2016-11-10 |
Last modified: | 2022-09-27 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 49 |
Chiral Atom Count | 2 |
Bond Count | 52 |
Aromatic Bond Count | 10 |
Chemical Component Summary | |
---|---|
Name | (8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide |
Synonyms | Lysergic acid diethylamide |
Systematic Name (OpenEye OEToolkits) | (6~{a}~{R},9~{R})-~{N},~{N}-diethyl-7-methyl-6,6~{a},8,9-tetrahydro-4~{H}-indolo[4,3-fg]quinoline-9-carboxamide |
Formula | C20 H25 N3 O |
Molecular Weight | 323.432 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | n1c4cccc2c4c(c1)CC3N(CC(C=C23)C(N(CC)CC)=O)C |
SMILES | CACTVS | 3.385 | CCN(CC)C(=O)[CH]1CN(C)[CH]2Cc3c[nH]c4cccc(C2=C1)c34 |
SMILES | OpenEye OEToolkits | 2.0.6 | CCN(CC)C(=O)C1CN(C2Cc3c[nH]c4c3c(ccc4)C2=C1)C |
Canonical SMILES | CACTVS | 3.385 | CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 |
Canonical SMILES | OpenEye OEToolkits | 2.0.6 | CCN(CC)C(=O)[C@H]1CN([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C |
InChI | InChI | 1.03 | InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1 |
InChIKey | InChI | 1.03 | VAYOSLLFUXYJDT-RDTXWAMCSA-N |
Drug Info: DrugBank
DrugBank ID | DB04829 |
---|---|
Name | Lysergic acid diethylamide |
Groups |
|
Description | Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder. Many emotionally intense experiences can lead to flashbacks when a person is reminded acutely of the original experience. However, not all published case reports of chronic flashbacks appear to describe an anxious hyper-vigilant state reminiscent of post-traumatic stress disorder. |
Synonyms |
|
Categories |
|
CAS number | 50-37-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
5-hydroxytryptamine receptor 1A | MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA... | unknown | |
5-hydroxytryptamine receptor 2B | MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQ... | unknown | agonist |
5-hydroxytryptamine receptor 6 | MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIAL... | unknown | |
Cytochrome P450 3A4 | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI... | unknown | substrate |
Cytochrome P450 2D6 | MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD... | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL263881 |
PubChem | 5761 |
ChEMBL | CHEMBL263881 |
ChEBI | CHEBI:6605 |
CCDC/CSD | LSDIBZ01 |